255 related articles for article (PubMed ID: 27852288)
21. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
Yang M; Li Y; Tian F
Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
[TBL] [Abstract][Full Text] [Related]
22. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers.
Ma G; Zhang H; Dong M; Zheng X; Ozaki I; Matsuhashi S; Guo K
Tumour Biol; 2013 Dec; 34(6):3879-85. PubMed ID: 23838800
[TBL] [Abstract][Full Text] [Related]
24. The Bidirectional Effects of Arsenic on miRNA-21: A Systematic Review and Meta-analysis.
Liu JQ; Niu Q; Hu YH; Li Y; Wang HX; Xu SZ; Ding YS; Li SG; Ma RL
Biomed Environ Sci; 2018 Sep; 31(9):654-666. PubMed ID: 30369344
[TBL] [Abstract][Full Text] [Related]
25. Defining the regulatory role of programmed cell death 4 in laryngeal squamous cell carcinoma.
Xu YT; Chen RQ; Lin GB; Fang XL; Yu SJ; Liang XH; Zhang R
Biochem Cell Biol; 2018 Oct; 96(5):522-538. PubMed ID: 29510060
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
Li L; Zhou L; Li Y; Lin S; Tomuleasa C
J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
28. Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis.
Chen S; Huang L; Sun K; Wu D; Li M; Li M; Zhong B; Chen M; Zhang S
PLoS One; 2015; 10(5):e0125480. PubMed ID: 25974088
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic significance of homeobox transcript antisense RNA expression in various cancers: A meta-analysis.
Min SN; Wei T; Wang XT; Wu LL; Yu GY
Medicine (Baltimore); 2017 Jun; 96(23):e7084. PubMed ID: 28591050
[TBL] [Abstract][Full Text] [Related]
30. Krüppel-like factor 4 expression in solid tumor prognosis: A meta-analysis.
Yu M; Hao B; Zhan Y; Luo G
Clin Chim Acta; 2018 Oct; 485():50-59. PubMed ID: 29940144
[TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma.
Wang X; Wei Z; Gao F; Zhang X; Zhou C; Zhu F; Wang Q; Gao Q; Ma C; Sun W; Kong B; Zhang L
Anticancer Res; 2008; 28(5B):2991-6. PubMed ID: 19031945
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features and prognostic significance of C5aR in human solid tumors: a Meta-analysis.
Wang Z; Yu W; Qiang Y; Ma F; Ding P; Wang Y
BMC Cancer; 2021 Oct; 21(1):1136. PubMed ID: 34688269
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis.
Li MX; Bi XY; Huang Z; Zhao JJ; Han Y; Li ZY; Zhang YF; Li Y; Chen X; Hu XH; Zhao H; Cai JQ
PLoS One; 2015; 10(5):e0127356. PubMed ID: 26024373
[TBL] [Abstract][Full Text] [Related]
34. Association Between Pretreatment Serum Apolipoprotein A1 and Prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of high FOXO3a expression in patients with solid tumors: A meta-analysis and systematic review.
Wang C; Tu X; Jiang Y; Jiao P; Deng X; Xie Y; Zhang L
Int J Biol Markers; 2022 Jun; 37(2):210-217. PubMed ID: 35484793
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
Liu W; Xu J; Zhang C
Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
[TBL] [Abstract][Full Text] [Related]
37. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.
Shiota M; Izumi H; Tanimoto A; Takahashi M; Miyamoto N; Kashiwagi E; Kidani A; Hirano G; Masubuchi D; Fukunaka Y; Yasuniwa Y; Naito S; Nishizawa S; Sasaguri Y; Kohno K
Cancer Res; 2009 Apr; 69(7):3148-56. PubMed ID: 19318582
[TBL] [Abstract][Full Text] [Related]
38. Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators.
Leupold JH; Asangani IA; Mudduluru G; Allgayer H
Biosci Rep; 2012 Jun; 32(3):281-97. PubMed ID: 22111549
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of ZEB-1 in solid tumors: a meta-analysis.
Chen B; Chen B; Zhu Z; Ye W; Zeng J; Liu G; Wang S; Gao J; Xu G; Huang Z
BMC Cancer; 2019 Jun; 19(1):635. PubMed ID: 31248382
[TBL] [Abstract][Full Text] [Related]
40. Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus.
Kim YK; Kwon JT; Choi JY; Jiang HL; Arote R; Jere D; Je YH; Cho MH; Cho CS
Cancer Gene Ther; 2010 Nov; 17(11):751-60. PubMed ID: 20539318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
